Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

BACKGROUND: Prior to clinical trials of new TB drugs or therapeutic vaccines, it is necessary to develop monitoring tools to predict treatment outcomes in TB patients. Urine interferon gamma inducible protein 10 (IP-10) is a potential biomarker of treatment response in chronic hepatitis C virus infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Song Yee, Kim, Jungho, Kim, Deok Ryun, Kang, Young Ae, Bong, Sungyoung, Lee, Jonghee, Kim, Suyeon, Lee, Nam Suk, Sim, Bora, Cho, Sang-Nae, Kim, Young Sam, Lee, Hyejon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975508/
https://www.ncbi.nlm.nih.gov/pubmed/29843631
http://dx.doi.org/10.1186/s12879-018-3144-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975508/
https://www.ncbi.nlm.nih.gov/pubmed/29843631
http://dx.doi.org/10.1186/s12879-018-3144-3

Ejemplares similares